JP2010505818A5 - - Google Patents

Download PDF

Info

Publication number
JP2010505818A5
JP2010505818A5 JP2009531012A JP2009531012A JP2010505818A5 JP 2010505818 A5 JP2010505818 A5 JP 2010505818A5 JP 2009531012 A JP2009531012 A JP 2009531012A JP 2009531012 A JP2009531012 A JP 2009531012A JP 2010505818 A5 JP2010505818 A5 JP 2010505818A5
Authority
JP
Japan
Prior art keywords
caco
disease
chitin
pharmaceutical formulation
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009531012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010505818A (ja
Filing date
Publication date
Priority claimed from IL178495A external-priority patent/IL178495A/en
Application filed filed Critical
Publication of JP2010505818A publication Critical patent/JP2010505818A/ja
Publication of JP2010505818A5 publication Critical patent/JP2010505818A5/ja
Pending legal-status Critical Current

Links

JP2009531012A 2006-10-05 2007-10-07 甲殻類の胃石成分を含む組成物とその使用 Pending JP2010505818A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL178495A IL178495A (en) 2006-10-05 2006-10-05 Use of cancerous gastric components or artificial calcium containing carbonate, chitin and polypeptide preparations to treat calcium metabolism-related or calcium-signaling conditions
PCT/IL2007/001211 WO2008041236A2 (en) 2006-10-05 2007-10-07 Composition comprising crustacean gastrolith components, calcium carbonate and its use

Publications (2)

Publication Number Publication Date
JP2010505818A JP2010505818A (ja) 2010-02-25
JP2010505818A5 true JP2010505818A5 (cg-RX-API-DMAC7.html) 2010-11-18

Family

ID=39153987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009531012A Pending JP2010505818A (ja) 2006-10-05 2007-10-07 甲殻類の胃石成分を含む組成物とその使用

Country Status (14)

Country Link
US (2) US20100098774A1 (cg-RX-API-DMAC7.html)
EP (1) EP2068891B1 (cg-RX-API-DMAC7.html)
JP (1) JP2010505818A (cg-RX-API-DMAC7.html)
CN (1) CN101563091A (cg-RX-API-DMAC7.html)
AU (1) AU2007303786B2 (cg-RX-API-DMAC7.html)
CA (1) CA2665141C (cg-RX-API-DMAC7.html)
CY (1) CY1114930T1 (cg-RX-API-DMAC7.html)
DK (1) DK2068891T3 (cg-RX-API-DMAC7.html)
ES (1) ES2439741T3 (cg-RX-API-DMAC7.html)
IL (1) IL178495A (cg-RX-API-DMAC7.html)
PL (1) PL2068891T3 (cg-RX-API-DMAC7.html)
PT (1) PT2068891E (cg-RX-API-DMAC7.html)
SI (1) SI2068891T1 (cg-RX-API-DMAC7.html)
WO (1) WO2008041236A2 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8257750B2 (en) * 1999-04-30 2012-09-04 Kibow Biotech, Inc. Calcium carbonate compositions for preventing or treating hyperphosphatemia
US8802160B2 (en) 2007-10-22 2014-08-12 Amorphical Ltd. Stable amorphous calcium carbonate comprising phosphorylated amino acids
JP2015500333A (ja) * 2011-12-13 2015-01-05 アモーフィカル リミテッド. カルシウム吸収不良及び代謝性骨障害を治療するための非晶質炭酸カルシウム
EP2882687B1 (en) 2012-08-07 2018-10-10 Amorphical Ltd. Method for producing stabilized amorphous calcium carbonate
US20150374747A1 (en) * 2013-02-11 2015-12-31 Amorphical Ltd. Amorphous calcium carbonate for accelerated bone growth
CN103417635B (zh) * 2013-08-15 2015-05-20 张荣惠 接骨药
CA2956048C (en) 2014-07-31 2023-01-24 Amorphical Ltd. Encapsulated amorphous calcium carbonate compositions
AU2016273058B2 (en) * 2015-06-04 2021-05-20 Amorphical Ltd. Amorphous calcium carbonate stabilized with polyphosphates or bisphosphonates
US12121538B2 (en) 2015-06-04 2024-10-22 Amorphical Ltd. Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration
CN108471796A (zh) * 2015-12-14 2018-08-31 雀巢产品技术援助有限公司 用于促进脑的髓鞘形成的营养组合物和婴儿配方食品
EP4233907A3 (en) * 2015-12-14 2024-01-10 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas to promote myelination in the brain
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
KR102828392B1 (ko) 2016-01-18 2025-07-02 아모피컬 리미티드 신경, 근육 및 불임 질환 또는 병증의 치료를 위한 안정화된 무정형 탄산칼슘
AU2017210259B2 (en) 2016-01-18 2022-11-03 Amorphical Ltd. Stabilized amorphous calcium carbonate as a supplement for cell culture media
US12629390B2 (en) 2016-01-18 2026-05-19 Amorphical Ltd. Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions
IL266149B (en) * 2016-10-25 2022-08-01 Amorphical Ltd Amorphous calcium carbonate for treating a leukemia
MX2022000947A (es) 2019-07-23 2022-04-26 Amorphical Ltd Carbonato de calcio amorfo para mejorar el rendimiento deportivo.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237147A (en) 1974-01-04 1980-12-02 Monsanto Company Stabilized amorphous calcium carbonate
US4199496A (en) * 1974-09-05 1980-04-22 Johnson Edwin L Process for the recovery of chemicals from the shells of crustacea
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
US20060165784A1 (en) * 1997-05-06 2006-07-27 Zhao Jin R Calcium supplement
US20030077604A1 (en) * 2000-10-27 2003-04-24 Yongming Sun Compositions and methods relating to breast specific genes and proteins
JP2002205947A (ja) * 2000-12-11 2002-07-23 Chafflose Corporation 水虫治療薬
ES2295391T3 (es) * 2001-08-16 2008-04-16 Cmp Therapeutics Limited Microparticulas de quitina y sus usos medicos.
JP2004081739A (ja) * 2002-08-29 2004-03-18 Mitsuru Akashi ハイドロキシアパタイト−ポリマー複合材料の止血用組成物
AU2003271016A1 (en) * 2003-09-17 2005-04-06 Bio-Wave Institute Of Suzhou Hi-Tech New District Corporation, Ltd. Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis
ES2447747T3 (es) * 2004-05-26 2014-03-12 Ben Gurion University Of The Negev Research And Development Authority Composiciones administrables por vía oral que comprenden carbonato cálcico amorfo estable
AU2005296271A1 (en) * 2004-10-15 2006-04-27 University Of Tennessee Research Foundation Methods for inducing apoptosis in adipocytes

Similar Documents

Publication Publication Date Title
CA2665141C (en) Composition comprising crustacean gastrolith components and its use
CN105580987B (zh) 饲料用有机涂敷多孔质颗粒及其制备方法
CN106219720B (zh) 改善水质、增强免疫力、有益心脑血管疾病的复合矿物质晶体及其制备方法
CN101085880A (zh) 纳米层状碳酸钙基仿生复合材料及其合成方法
TW201607432A (zh) 利用家畜血液和貝殼的養魚飼料用或配合飼料輔助用有機塗敷多孔質顆粒及其製造方法
KR101896424B1 (ko) 다공성 미네랄 제조방법 및 이를 이용한 수용화된 다공성 미네랄 조성물 제조방법
ATE520627T1 (de) Calcium- und/oder magnesiumhydroxid mit höherer aktivität und seine zubereitung
Zhang et al. Fabrication of flower-like hydroxyapatite agglomerates with the assistant of bamboo membrane
TWI882135B (zh) 由發酵液製備胺基酸顆粒之方法
CN103936504A (zh) 一种微纳米矿物硒肥料的制备方法
CN107572493B (zh) 一种含松香官能团的蒲公英状空心羟基磷灰石的制备方法
Tan et al. Water-dispersible hydroxyapatite nanorods synthesized by a facile method
Li et al. Crystallization of dicalcium phosphate dihydrate with presence of glutamic acid and arginine at 37 C
JP2699946B2 (ja) 麦飯石飼料及びその製法
CN116535272B (zh) 一种富硒有机无机复混肥及其制备方法和使用方法
KR20180028146A (ko) 유해성분이 제거된 안정한 법제유황의 제조방법
CN108968075A (zh) 一种提高骨骼健康的组合物及其应用
CN107927344A (zh) 一种功能化营养舔砖及其制备方法
KR100761896B1 (ko) 고농도 미네랄 소금 제조방법
CN108658039A (zh) 一种水制氢材料及其制备方法和应用
Pazourková et al. Preparation of calcium deficient hydroxyapatite on vermiculite from China and Africa deposits
CN1857304A (zh) 控缓释型碘的补碘剂及制备方法和用途
US20160101129A1 (en) Medicinal Clay Preparation
JP3143413B2 (ja) 麦飯石粉末の製法及び外傷皮膚炎改善剤、入浴剤、消臭剤
Hasanuddin et al. Nano Calcium from Marine Fish Bones via High-Energy Ball Milling: A Potential Natural Supplement for Bone Health